Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | DFTX | BCRX | ||
| Company | Enliven Therapeutics Inc | Definium Therapeutics Inc | Biocryst Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.65 | 23.33 | 9.05 | ||
| High | 40.94 | 24.29 | 9.10 | ||
| Low | 39.02 | 23.30 | 8.82 | ||
| Latest | 39.57 | 24.19 | 8.91 | ||
| Change | -1.08 | +0.71 | -0.19 | ||
| % Change | -2.66% | +3.02% | -2.09% | ||
| Volume | 747,900 | 2,307,900 | 3,232,300 | ||
| 20-Day Average Volume | 626,490 | 1,602,970 | 5,087,555 | ||
| Previous Close | 40.65 | 23.48 | 9.10 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.33 | 22.10 | 8.90 | ||
| 20-Day Raw Stochastic | 15.09% | 97.98% | 55.28% | ||
| 20-Day Relative Strength | 47.65 | 61.87 | 49.97 | ||
| Weighted Alpha | +51.64 | +242.12 | -6.86 | ||
| Today's Opinion | 56% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.34% since 05/21/26 | +6.80% since 05/21/26 | +6.45% since 05/21/26 | ||
| Low | 39.02 on 05/29/26 | 22.34 on 05/22/26 | 8.11 on 05/26/26 | ||
| High | 43.05 on 05/22/26 | 24.29 on 05/29/26 | 9.23 on 05/27/26 | ||
| 1-Month | |||||
| %Chg | -6.67% since 04/29/26 | +18.06% since 04/29/26 | -0.89% since 04/29/26 | ||
| Low | 38.58 on 05/19/26 | 19.33 on 05/19/26 | 7.78 on 05/06/26 | ||
| High | 45.14 on 05/13/26 | 24.29 on 05/29/26 | 9.82 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | +33.28% since 02/27/26 | +38.62% since 02/27/26 | +1.83% since 02/27/26 | ||
| Low | 26.70 on 03/18/26 | 16.55 on 03/03/26 | 7.78 on 05/06/26 | ||
| High | 48.53 on 04/17/26 | 26.25 on 04/20/26 | 10.32 on 03/20/26 | ||
| 6-Month | |||||
| %Chg | +83.19% since 11/28/25 | +91.23% since 11/28/25 | +24.09% since 11/28/25 | ||
| Low | 14.78 on 01/06/26 | 11.80 on 12/04/25 | 6.23 on 02/05/26 | ||
| High | 48.53 on 04/17/26 | 26.25 on 04/20/26 | 10.32 on 03/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,410,011 | 2,411,695 | 2,264,592 | ||
| Shares Outstanding, K | 60,905 | 99,698 | 254,163 | ||
| Annual Sales | 0 | 0 | 874,840,000 | ||
| Annual Net Income | -103,690,000 | -183,790,000 | 263,860,000 | ||
| Last Quarter Sales | 0 | 0 | 156,410,000 | ||
| Last Quarter Net Income | -23,630,000 | -77,100,000 | -721,810,000 | ||
| 60-Month Beta | 0.32 | 2.37 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 05/07/26 | -0.71 on 05/07/26 | -0.03 on 05/06/26 | ||
| Earnings Date | 08/12/26 | 07/30/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 7.00 | ||